- Home
- PGEN vs RMM Comparison
PGEN vs RMM Comparison
Compare PGEN & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- RMM
- Stock Information
- Founded
- PGEN 1998
- RMM 2019
- Country
- PGEN United States
- RMM United States
- Employees
- PGEN 25
- RMM N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- RMM Trusts Except Educational Religious and Charitable
- Sector
- PGEN Health Care
- RMM Finance
- Exchange
- PGEN Nasdaq
- RMM Nasdaq
- Market Cap
- PGEN 419.2M
- RMM 271.2M
- IPO Year
- PGEN N/A
- RMM N/A
- Fundamental
- Price
- PGEN $1.62
- RMM $13.55
- Analyst Decision
- PGEN Strong Buy
- RMM
- Analyst Count
- PGEN 3
- RMM 0
- Target Price
- PGEN $6.00
- RMM N/A
- AVG Volume (30 Days)
- PGEN 2.0M
- RMM 66.5K
- Earning Date
- PGEN 08-13-2025
- RMM 01-01-0001
- Dividend Yield
- PGEN N/A
- RMM 7.33%
- EPS Growth
- PGEN N/A
- RMM N/A
- EPS
- PGEN N/A
- RMM 0.96
- Revenue
- PGEN $4,201,000.00
- RMM N/A
- Revenue This Year
- PGEN $158.57
- RMM N/A
- Revenue Next Year
- PGEN $1,086.91
- RMM N/A
- P/E Ratio
- PGEN N/A
- RMM $15.55
- Revenue Growth
- PGEN N/A
- RMM N/A
- 52 Week Low
- PGEN $0.65
- RMM $12.32
- 52 Week High
- PGEN $2.17
- RMM $16.10
- Technical
- Relative Strength Index (RSI)
- PGEN 63.16
- RMM 51.90
- Support Level
- PGEN $1.39
- RMM $13.28
- Resistance Level
- PGEN $1.70
- RMM $13.55
- Average True Range (ATR)
- PGEN 0.10
- RMM 0.11
- MACD
- PGEN 0.01
- RMM 0.02
- Stochastic Oscillator
- PGEN 75.00
- RMM 77.81
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.